Innoviva
INVA
#5502
Rank
C$2.15 B
Marketcap
C$29.77
Share price
1.26%
Change (1 day)
22.54%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): C$0.57 Billion

According to Innoviva's latest financial reports the company's current earnings are C$0.43 Billion. In 2025 the company made an earning of C$0.46 Billion, an increase over its 2024 earnings that were of C$53.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.57 B23.71%
2025 C$0.46 B774.24%
2024 C$53.25 M-80.74%
2023 C$0.27 B-32.36%
2022 C$0.40 B-35.56%
2021 C$0.63 B25.7%
2020 C$0.50 B52.11%
2019 C$0.33 B10.77%
2018 C$0.29 B56.59%
2017 C$0.19 B125.53%
2016 C$84.8 M-417.36%
2015 -C$26.73 Million-74.49%
2014 -C$0.11 Billion-25.19%
2013 -C$0.14 Billion430.06%
2012 -C$26.42 Million-83.92%
2011 -C$0.17 Billion39.82%
2010 -C$0.12 Billion2.84%
2009 -C$0.12 Billion-8.62%
2008 -C$0.13 Billion-47.92%
2007 -C$0.25 Billion-5.92%
2006 -C$0.26 Billion19.8%
2005 -C$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.12 Billion-119.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.87 Million-104.33%๐Ÿ‡บ๐Ÿ‡ธ USA